[{"Assets_0_FY_USD":47666000000.0,"EarningsPerShareBasic_4_FY_USD":0.38,"EarningsPerShareDiluted_4_FY_USD":0.38,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":798000000.0,"NetIncomeLoss_4_FY_USD":417000000.0,"NetIncomeLossConverted_4_FY_USD":456000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":15878000000.0,"StockholdersEquity_0_FY_USD":10278000000.0,"StockholdersEquityConverted_0_FY_USD":11244000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1107000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1102000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20220209"}]